These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2841805)
21. Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV). Zhou W; Cook RF; Cook SJ; Hammond SA; Rushlow K; Ghabrial NN; Berger SL; Montelaro RC; Issel CJ Vet Microbiol; 2002 Aug; 88(2):127-51. PubMed ID: 12135633 [TBL] [Abstract][Full Text] [Related]
22. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Howe L; Leroux C; Issel CJ; Montelaro RC J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301 [TBL] [Abstract][Full Text] [Related]
23. Identification of sequences encoding the equine infectious anemia virus tat gene. Noiman S; Gazit A; Tori O; Sherman L; Miki T; Tronick SR; Yaniv A Virology; 1990 May; 176(1):280-8. PubMed ID: 2158694 [TBL] [Abstract][Full Text] [Related]
24. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection. Chen C; Li F; Montelaro RC J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809 [TBL] [Abstract][Full Text] [Related]
25. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2. Schiltz RL; Shih DS; Rasty S; Montelaro RC; Rushlow KE J Virol; 1992 Jun; 66(6):3455-65. PubMed ID: 1316461 [TBL] [Abstract][Full Text] [Related]
26. Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins. Ball JM; Rao VS; Robey WG; Issel CJ; Montelaro RC J Virol Methods; 1988; 19(3-4):265-77. PubMed ID: 2836462 [TBL] [Abstract][Full Text] [Related]
27. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies. Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167 [TBL] [Abstract][Full Text] [Related]
28. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus. Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Cook RF; Cook SJ; Berger SL; Leroux C; Ghabrial NN; Gantz M; Bolin PS; Mousel MR; Montelaro RC; Issel CJ Virology; 2003 Sep; 313(2):588-603. PubMed ID: 12954224 [TBL] [Abstract][Full Text] [Related]
30. Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. Du J; Wang X; Ma J; Wang J; Qin Y; Zhu C; Liu F; Shao Y; Zhou J; Qiao W; Liu X Retrovirology; 2014 Mar; 11():26. PubMed ID: 24656154 [TBL] [Abstract][Full Text] [Related]
31. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat). Derse D; Dorn P; DaSilva L; Martarano L Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129 [TBL] [Abstract][Full Text] [Related]
32. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine. Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668 [TBL] [Abstract][Full Text] [Related]
33. The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Noiman S; Yaniv A; Tsach T; Miki T; Tronick SR; Gazit A Virology; 1991 Oct; 184(2):521-30. PubMed ID: 1653485 [TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Olmsted RA; Hirsch VM; Purcell RH; Johnson PR Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8088-92. PubMed ID: 2813380 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. Rice NR; Henderson LE; Sowder RC; Copeland TD; Oroszlan S; Edwards JF J Virol; 1990 Aug; 64(8):3770-8. PubMed ID: 2164597 [TBL] [Abstract][Full Text] [Related]
36. Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors. Cunningham TP; Montelaro RC; Rushlow KE Gene; 1993 Feb; 124(1):93-8. PubMed ID: 8382658 [TBL] [Abstract][Full Text] [Related]
37. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Rwambo PM; Issel CJ; Hussain KA; Montelaro RC Arch Virol; 1990; 111(3-4):275-80. PubMed ID: 1693846 [TBL] [Abstract][Full Text] [Related]
38. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines. Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613 [TBL] [Abstract][Full Text] [Related]
39. Structural and functional characterization of EIAV gp45 fusion peptide proximal region and asparagine-rich layer. Duan L; Du J; Wang X; Zhou J; Wang X; Liu X Virology; 2016 Apr; 491():64-72. PubMed ID: 26874586 [TBL] [Abstract][Full Text] [Related]
40. Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat. Sherman L; Gazit A; Yaniv A; Kawakami T; Dahlberg JE; Tronick SR J Virol; 1988 Jan; 62(1):120-6. PubMed ID: 2824840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]